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of adult and pediatric OCD to date. We analyzed diffusion tensor imaging metrics from 700 adult
patients and 645 adult controls, as well as 174 pediatric patients and 144 pediatric controls across 19
sites participating in the ENIGMA OCD Working Group, in a cross-sectional case-control magnetic
resonance study. We extracted measures of fractional anisotropy (FA) as main outcome, and mean
diffusivity, radial diffusivity, and axial diffusivity as secondary outcomes for 25 white matter regions. We
meta-analyzed patient-control group differences (Cohen’s d) across sites, after adjusting for age and sex,
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White matter microstructure and its relation to
clinical features of obsessive–compulsive disorder:
findings from the ENIGMA OCD Working Group
Abstract
Microstructural alterations in cortico-subcortical connections are thought to be present in obsessive–compulsive
disorder (OCD). However, prior studies have yielded inconsistent findings, perhaps because small sample sizes
provided insufficient power to detect subtle abnormalities. Here we investigated microstructural white matter
alterations and their relation to clinical features in the largest dataset of adult and pediatric OCD to date. We analyzed
diffusion tensor imaging metrics from 700 adult patients and 645 adult controls, as well as 174 pediatric patients and
144 pediatric controls across 19 sites participating in the ENIGMA OCD Working Group, in a cross-sectional case-control
magnetic resonance study. We extracted measures of fractional anisotropy (FA) as main outcome, and mean diffusivity,
radial diffusivity, and axial diffusivity as secondary outcomes for 25 white matter regions. We meta-analyzed patient-
control group differences (Cohen’s d) across sites, after adjusting for age and sex, and investigated associations with
clinical characteristics. Adult OCD patients showed significant FA reduction in the sagittal stratum (d=−0.21, z=
−3.21, p= 0.001) and posterior thalamic radiation (d=−0.26, z=−4.57, p < 0.0001). In the sagittal stratum, lower FA
was associated with a younger age of onset (z= 2.71, p= 0.006), longer duration of illness (z=−2.086, p= 0.036), and
a higher percentage of medicated patients in the cohorts studied (z=−1.98, p= 0.047). No significant association
with symptom severity was found. Pediatric OCD patients did not show any detectable microstructural abnormalities
compared to controls. Our findings of microstructural alterations in projection and association fibers to posterior brain
regions in OCD are consistent with models emphasizing deficits in connectivity as an important feature of this
disorder.
Introduction
Abnormalities in cerebral white matter (WM) are rele-
vant to models of anomalous brain circuitry that posit
deficits in connectivity in obsessive–compulsive disorder
(OCD). OCD has a childhood onset in over 50% of all cases,
and most childhood-onset OCD cases persist into adult-
hood1. Diffusion tensor imaging (DTI) allows the study of
WM at the microstructural level through the analysis of
intrinsic, three-dimensional diffusion properties of water
within brain tissues2. Prior DTI studies in OCD3–5 suggest
that microstructural alterations are present in a number of
WM areas. However, results across studies are inconsistent,
with contrasting or conflicting effects of OCD on DTI
metrics6. Sources of heterogeneity may include methodo-
logical factors (e.g., imaging acquisition and data proces-
sing), clinical characteristics, and variations in demographic
or socioeconomic factors. More importantly, sample size
variations may impact reported findings, as small studies
may have insufficient power to detect subtle alterations7.
Brain imaging consortia offer new opportunities, pooling
data and findings from around the world to achieve an
appropriate sample size. The OCD working group of the
Enhancing Neuro-Imaging Genetics through Meta-Analysis
(ENIGMA) consortium8, is one such collaboration.
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Previous findings from the working group focused on
subcortical and cortical brain gray matter abnormalities,
using subcortical volumes, cortical thickness, and surface
area quantification algorithms. An initial analysis of data
from 3589 individuals showed distinct subcortical volume
abnormalities in adults (smaller hippocampal and larger
pallidal volumes) and unmedicated children (larger tha-
lamic volume) with OCD9. The second study focused on
cortical gray matter differences and showed a lower surface
area for the transverse temporal cortex and a thinner
inferior parietal cortex in adult patients. In pediatric OCD
patients compared to healthy controls, significantly thinner
inferior and superior parietal cortices were found10. Medi-
cation status was associated with structural differences in
both pediatric and adult OCD.
Here we aimed to investigate WM microstructural
alterations in adult and pediatric OCD using data from
the ENIGMA OCD working group, in the subset of par-
ticipants that had collected diffusion magnetic resonance
imaging (MRI). DTI metrics in 700 adult patients were
compared to those of 645 adult controls, and separately,
174 pediatric patients were compared to 144 pediatric
controls. Analyses also aimed to investigate associations
between WM microstructure and demographic and clin-
ical variables. As prior meta-analytic findings in frontal
and callosal regions have been inconsistent (with either
higher11 or lower3,11 fractional anisotropy (FA) in anterior
midline tracts), with more homogenous findings for
fronto-temporal and fronto-parietal intra-hemispheric
bundles, we expected to find microstructural alterations
(as reflected by lower FA3,4,6,11) in the long tracts con-




The ENIGMA OCD Working Group includes 19
international research institutes. Previous literature
(including studies from the present Working Group9,10)
showed different patterns of effects in pediatric and adult
cohorts; thus, we performed separate meta-analyses for
adult and pediatric data. Globally, we analyzed data from
1345 adults (including 700 OCD patients and 645 controls,
aged ≥18) and 318 children (including 174 OCD patients
and 144 controls). The diagnosis of psychiatric disorders
including OCD and other comorbid conditions (if any)
was made using a structured or semi-structured interview;
the Structured Clinical Interview for DSM-IV [(First
et al.12) n= 9 datasets], the Mini-International Neu-
ropsychiatric Interview [(Sheehan et al.13) n= 3 datasets],
or the schedule for affective disorders and schizophrenia
for school-aged children: Present and Lifetime Version [K-
SADS-PL14; n= 7 datasets]. Patients were administered
the Yale-Brown Obsessive–Compulsive Scale (YBOCS)15
and the Child YBOCS16 to assess symptom severity. These
tools are clinician-rated, 10-item scales, with each item
rated from 0 (no symptoms) to 4 (extreme symptoms; total
range, 0–40), with separate subtotals for the severity of
obsessions and compulsions.
Common exclusion criteria across sites included: (1)
history of psychoactive substance dependence or abuse
during lifetime, (2) history of neurologic illness or brain
injury, (3) presence of any brain pathology as instantiated
by standard magnetic resonance imaging (MRI) exams
(including T1-weighted and standard clinical sequences),
(4) dementia diagnosis according to DSM-IV-TR criteria.
Tables 1 and 2 show the demographic and clinical
characteristics of the participants from each site.
All local IRBs approved the use of measures extracted
from completely anonymized data.
Image acquisition and processing
Harmonized preprocessing, including brain extraction,
eddy current correction, movement correction, echo-
planar imaging-induced distortion correction and tensor
fitting, was carried out at each site, using protocols and
quality control pipelines provided by the ENIGMA-DTI
working group (http://enigma.ini.usc.edu/protocols/dti-
protocols/) and already employed to pool harmonized
DTI analyses from around the world17–19.
Once tensors were estimated, each site conducted a
harmonized image analysis for FA quantification using the
ENIGMA-DTI protocol, consisting of the tract-based
spatial statistics (TBSS)20 analytic method modified to
project individual FA values to the ENIGMA-DTI skele-
ton. Tract-wise regions of interest (ROIs), derived from
the Johns Hopkins University21 WM parcellation atlas,
were used to extract the mean FA across the full skeleton
and mean FA values for 25 ROIs.
Diffusivity measures (i.e., mean diffusivity (MD), axial
diffusivity (AD), and radial diffusivity (RD)) were also
derived for secondary analysis (i.e., the analyses were
performed only in those WM regions, if any, where FA
was significant). In the main analyses, we combined left
and right ROI across hemispheres, as we had no a priori
hypotheses regarding lateralized effects on FA.
Statistical analysis
At each site, Cohen’s d effect sizes were calculated for
differences in FA between patients and healthy controls.
Age, sex, age-by-sex interaction, and quadratic covariates
of age2 and age2-by-sex interaction were included in the
model, as linear and nonlinear age and sex interactions
have been reported for FA17. Subsequently, a random
effects meta-analysis was run at the coordinating site
using Comprehensive Meta-Analysis (CMA, version 2,
Biostat, Englewood, NJ) to combine individual site effect
sizes. Heterogeneity scores (I2; lower values indicate lower
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variance in the effect size estimates across studies) were
also computed for each test.
Effect sizes are reported as overall Cohen’s d values for
case/control effects and z-scores, and were considered sig-
nificant if p < 0.05. The stability of the overall effect size
estimate was tested using a ‘leave one out’ sensitivity ana-
lysis. This analysis shows how the overall effect size changes
if one dataset at a time is removed, assessing whether
potential results are site-dependent with between-sites
variations potentially deriving from variability in study
population characteristics (sampling error). Furthermore, to
ascertain whether the estimated effect size varied as a
function of clinical characteristics, mixed-effects meta-
regressions were performed on FA, using age of onset,
duration of illness, symptom severity, and percentage of
medicated patients in the patients’ dataset as regressors.
The influence of medication status was also explored
through a mixed-effects sub-group analysis, comparing
effect sizes in medicated (n= 8) and unmedicated (n= 3)
patient cohorts. These analyses were primarily run in those
WM areas where effect sizes were significant and stable
according to the leave-one-out analyses. Ancillary analyses
explored the effect of clinical variables on FA also in WM
areas where only partly stable results were observed (i.e.,
where the removal of 1 or 2 studies affected significance)
Results
Demographics and clinical characteristics of the parti-
cipants in each site are shown in Tables 1 and 2.
Adult Cohort
Table 3 indicates the 5 out of 25 regions with lower FA
in patients compared to controls. These are the genu of
the corpus callosum (GCC, d=−0.17, z=−2, p=
0.045), the posterior corona radiata (PCR, d=−0.16,
z=−2.38, p= 0.017), the posterior thalamic radiation
(PTR, d=−0.261, z=−4.57, p < 0.0001), the sagittal
stratum (SS, d=−0.21, z=−3.21, p= 0.001) and the
uncinate fasciculus (UNC, d=−0.18, z=−2.49, p=
0.013) (see Fig. 1).
Heterogeneity scores revealed a significant high var-
iance for GCC (I2= 53.61, p= 0.018) only, whereas PCR
(I2= 26.25, p= 0.19), PTR (I2= 6.61, p= 0.38), SS (I2=
24.43, p= 0.21), and UNC (I2= 37.4, p= 0.1) showed
non-significant variance between sites.
The sensitivity analysis showed that PTR and SS were
the only WM tracts where the removal of individual
datasets did not affect significance. For the other WM
tracts results are more controversial, since for GCC the
exclusion of six sites determined a loss of significance of
the model, while for PCR and UNC the exclusion of two
Table 1 Demographic and clinical characteristics of patients with obsessive–compulsive disorder (OCD) and control
subjects.








Age (years) 31.4 ± 9.9 30.7 ± 10 14.5 ± 2.3 14.3 ± 2.5
OCD illness severity score 25 ± 7.1 – 20.7 ± 7.8 –
Age at onset 19.1 ± 8.4 – 13.1 ± 5.3 –
N (%) N (%) N (%) N (%)
Male 405 (58) 378 (59) 94 (53) 74 (51.3)
Medication use at time of scan 269 (39) – 112 (64) –
Current comorbid disorders
Anxiety 74a (11) – 27b (23) –
Major depression 60c (10) – 10b (9) –
OCD symptom dimension
Aggressive/checking 418d (79) – 82e (75) –
Contamination/cleaning 358d (68) – 74e (68) –
Symmetry/ordering 378d (62) – 72e (66) –
Sexual/religious 229d (44) – 47e (43)
Hoarding 115d (22) – 45e (41) –
aData available for 625 patients.
bData available for 117 patients.
cData available for 610 patients.
dData available for 525 patients.
eData available for 109 patients.
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sites determined a loss of significance of the model (see
Supplementary Table 1).
As secondary analyses, we also investigated diffusivity
measures (i.e., MD, AD, and RD) in those WM regions
where FA was significantly reduced in OCD. Results
revealed that patients diagnosed with OCD showed higher
MD in the SS (d= 0.21, z= 2.75, p= 0.006) and higher RD
in PTR and SS (d= 0.16, p= 0.002 for PTR and d= 0.21,
p= 0.007 for SS). No significant results were found for AD.
As stated, meta-regressions were primarily run in regions
where effect sizes were significant and stable (i.e., PTR and
SS). In the SS of adults diagnosed with OCD, lower FA was
significantly associated with younger age of onset (z= 2.71,
p= 0.006), longer duration of illness (z=−2.09, p= 0.036)
and a higher percentage of medicated patients (z=−1.98,
p= 0.047; see Fig. 2). Mixed-effects sub-groups analysis
showed a significant difference (q value(df= 1)= 5.27,
p= 0.022) between the effect sizes in medicated (N= 544,
d=−0.274, p= <0.0001) and unmedicated (N= 158, d=
0.046, p= 0.72) patients. No relationship was found
between FA values of the PTR and clinical measures. No
relationship was found between FA and YBOCS scores.
Ancillary analyses in those WM areas where results were
unstable according to the leave-one-out analyses (i.e., PCR
and UNC), revealed that lower FA was associated with
longer duration of illness (z=−2.308, p= 0.021) and
higher percentage of medicated patients (z=−2.817, p=
0.005) in the PCR, and with higher percentage of medi-
cated patients (z=−2.453, p= 0.014) in the UNC.
Pediatric cohort
In the pediatric cohort, patients showed no detectable
FA abnormalities in any of the regions studied (see Table
4 for statistical details).
Table 2 (a) Breakdown, by site, of clinical characteristics of adult patients with obsessive–compulsive disorder (OCD) in
the ENIGMA OCD Working Group samples; (b) Breakdown, by site, of clinical characteristics of pediatric patients with
obsessive–compulsive disorder (OCD) in the ENIGMA OCD Working Group samples.
Site OCD/HC (N) Medicated (%) Age of onset Duration of illness YBOCS score Lifetime anxiety (%) Lifetime depression %
(a)
Amsterdam 38/34 0 15.1 ± 6.8 23.7 ± 12.8 21.3 ± 6.1 42.1 47.4
Bangalore 158/131 39.9 22.3 ± 7.7 7.2 ± 5.2 25.5 ± 6.5 8.9 7
Capetown 22/23 40.9 13.2 ± 5.7 17.2 ± 11.5 23 ± 4.2 0 0
Kyoto 35/41 0 25.2 ± 9 7.7 ± 6.2 21.9 ± 6.6 8.6 0
Milan 63/65 60.3 15.6 ± 6.2 18.9 ± 11.6 31.4 ± 5.2 1.6 7.9
Mount Sinai 16/18 81.3 12.4 ± 5.7 15.1 ± 6.7 19.9 ± 5.9 50 18.8
Munich 73/60 60.3 17.6 ± 6.7 13.5 ± 10.3 20.8 ± 6.2 8.2 23.3
Rome 77/111 94.8 16.8 ± 8 17.3 ± 12.8 23.2 ± 9.3 10.4 9.1
Sao Paulo 37/30 43.2 12.8 ± 5.9 26.3 ± 13.5 29.2 ± 6.2 73 83.8
Shangai 83/45 0 24 ± 9.9 6 ± 5.9 26.2 ± 4.7 0 0
Seoul 98/87 13.3 19.1 ± 7.2 6.2 ± 7 25.8 ± 6.9 1 2
(b)
Bangalore 13/13 85 12.8 ± 1.9 1.5 ± 1 21 ± 7.6 23.1 23.1
Barcelona 52/27 78.8 12.2 ± 2.5 1.5 ± 2.1 20.8 ± 7.6 28.8 5.8
British
Columbia
13/16 86.7 11.1 ± 3.5 3.3 ± 2.7 14 ± 6 33.3 0
Calgary 19/18 0 NA NA 23.1 ± 4.7 NA NA
Chiba 20/6 40 11.9 ± 2.4 2.1 ± 1.8 27 ± 6.2 10 0
Oxford 13/18 63.6 11.7 ± 3 4.7 ± 3.2 20 ± 7.3 31.8 22.7
Yale 22/23 52.2 NA NA 26.9 ± 4.5 43.5 39.1
Zurich 22/23 57.1 11.1 ± 2.4 4.7 ± 2.3 16.1 ± 10.1 42.9 0
YBOCS Yale-Brown Obsessive–Compulsive Scale, NA not available.
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Discussion
In the largest coordinated meta-analysis of WM in OCD
to date, we demonstrated specific regional WM alterations
in adults with OCD, with lower FA in GCC, PCR, PTR, SS,
and UNC. Such results were stable and independent of
sampling error in the PTR and SS only. Secondary analyses
on other diffusion parameters revealed that OCD showed
higher MD in the SS and higher RD in PTR and SS.
Meta-regressions indicated that lower FA in the SS is
associated with younger age at onset, longer duration of
illness, and being on medication, but not with symptom
severity suggesting that—as observed for cortical thick-
ness and subcortical volumes in OCD—, the reported
alterations may be markers of the disorder. We did not
find case-control differences in WM microstructure of
pediatric subjects.
A role for cerebral WM and oligodendrocytes (the mye-
linating cells of the central nervous system) in the patho-
physiology of many psychiatric disorders has been supported
by growing research evidence4,22, suggesting abnormalities
of myelination status as a possible pathogenic mechanism23.
Specifically, altered myelin-related maturational growth may
explain the enhanced risk for psychiatric disorders during
the transition from childhood to adulthood24,25, an age
window of intense ongoing brain development23.
Although FA is a general measure of microstructure—
including variation in regional myelination levels, such as
axon demyelination or loss, myelin loss or increased
Table 3 FA meta-analysis metrics for the adult sample.
Effect size and 95% confidence interval Heterogeneity
ROI Cohen’s d S.E. Lower limit Upper limit z value p value q value p value I squared
ACR −0.1164 0.0983 −0.3091 0.0763 −1.1839 0.2364 29.1988 0.0012 65.7520
ALIC −0.0584 0.0971 −0.2488 0.1320 −0.6013 0.5477 28.5200 0.0015 64.9369
AverageFA −0.1968 0.1091 −0.4107 0.0171 −1.8036 0.0713 35.9099 0.0001 72.1525
BCC −0.1119 0.1076 −0.3227 0.0990 −1.0398 0.2984 34.9932 0.0001 71.4230
CC −0.1558 0.1067 −0.3650 0.0533 −1.4606 0.1441 34.4018 0.0002 70.9317
CGC −0.0626 0.0789 −0.2173 0.0920 −0.7938 0.4273 18.9453 0.0410 47.2164
CGH −0.0677 0.0650 −0.1951 0.0598 −1.0404 0.2982 13.2641 0.2093 24.6083
CR −0.1294 0.0962 −0.3179 0.0591 −1.3454 0.1785 27.9259 0.0019 64.1910
CST 0.0641 0.0577 −0.0490 0.1772 1.1106 0.2667 10.8843 0.3666 8.1241
EC −0.1173 0.0868 −0.2873 0.0528 −1.3513 0.1766 22.7693 0.0116 56.0812
FX −0.1063 0.0745 −0.2523 0.0398 −1.4259 0.1539 16.9566 0.0753 41.0259
FXST −0.0804 0.0968 −0.2701 0.1093 −0.8307 0.4062 28.3405 0.0016 64.7148
GCC −0.1696 0.0845 −0.3352 −0.0041 −2.0085 0.0446 21.5584 0.0175 53.6144
IC −0.0158 0.0887 −0.1896 0.1581 −0.1776 0.8590 23.8155 0.0081 58.0106
IFO −0.0350 0.0772 −0.1864 0.1164 −0.4531 0.6505 18.1854 0.0519 45.0108
PCR −0.1570 0.0660 −0.2863 −0.0277 −2.3803 0.0173 13.5590 0.1941 26.2484
PLIC 0.0406 0.0763 −0.1090 0.1903 0.5321 0.5947 17.7645 0.0591 43.7078
PTR −0.2619 0.0573 −0.3742 −0.1495 −4.5689 0.0000 10.7084 0.3807 6.6151
RLIC −0.0256 0.0823 −0.1869 0.1356 −0.3117 0.7553 20.5308 0.0246 51.2926
SCC −0.1223 0.0882 −0.2952 0.0506 −1.3868 0.1655 23.5299 0.0090 57.5008
SCR −0.0664 0.0776 −0.2184 0.0856 −0.8565 0.3917 18.3052 0.0500 45.3707
SFO −0.0776 0.0813 −0.2370 0.0818 −0.9545 0.3399 20.0600 0.0287 50.1495
SLF −0.1189 0.1066 −0.3278 0.0901 −1.1149 0.2649 34.3842 0.0002 70.9169
SS −0.2090 0.0651 −0.3367 −0.0814 −3.2100 0.0013 13.2328 0.2109 24.4304
UNC −0.1799 0.0723 −0.3216 −0.0382 −2.4885 0.0128 15.9772 0.1003 37.4109
Cohen’s d values, their s.e., lower and upper limits, p values and I2 (heterogeneity) values after meta-analysis for differences between OCD patients and healthy
controls.
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extracellular space—it does not provide a physiologically
specific explanation of WM abnormalities26. In our study,
higher MD and RD (and the absence of changes in AD) in
the same bundles supports the hypothesis that lower FA
reflects a disruption of myelin sheaths27,28, given that RD
is a putative myelin marker26.
The association between myelin degradation in the SS
and longer illness duration together with the absence of a
detectable alteration in pediatric patients, suggest that
neuroplastic changes may reflect prolonged symptoma-
tology, since compulsively engaging in a particular
behavior or cognitive process has been suggested to alter
brain structure29,30. Moreover, symptoms indicative of
obsessive–compulsive traits are related to individual
myelination over time, even in otherwise healthy samples.
This suggests that the mechanisms underlying compul-
sivity have long-lasting effects on brain development,
possibly affecting myelination trajectories during ado-
lescence, with enduring effects into adulthood23. Alter-
natively, the paucity of extrinsic factors regulating the
development of myelinating glia31 could have driven the
altered myelination and its association with prolonged
illness. Indeed, impoverished environment is both the
cause and the consequence of mental illness in general,
and of compulsivity in particular32.
Lower FA in the SS was related to medication status (this
was true also for PCR and UNC), and present only in the
cohort of medicated patient. Moreover, the effect remained
significant across combinations of datasets when only
medicated patients were considered. Therefore, we cannot
rule out the possibility that medication impacts WM
microstructure. Indeed, drug-induced reductions in the FA
of several WM tracts may be seen in OCD33 and long-term
treatment exposure may negatively influence the pro-
liferation of oligodendrocytes and their myelination of
axons27,34–36. Our findings are consistent with a previous
large multimodal meta-analysis3 where increased WM
volume and decreased FA were especially pronounced in
OCD samples with a high proportion of medicated
patients. That said, given the cross-sectional nature of the
present study, our interpretation here is a tentative one,
and requires confirmation with a longitudinal design.
PTR and the SS (but also the PCR) convey projection
fibers to the posterior part of the brain. Thus, our results
strengthen the hypothesis that OCD involves abnormalities
affecting an extensive network of regions11,37. Both bundles
Fig. 1 Left panel—fractional anisotropy (FA) differences between OCD patients and healthy controls for 25 white matter (WM) regions.
Gradient bar indicates Cohen’s d effect sizes after meta-analysis. Right Panel- Cohen’s d effect sizes after meta-analysis, including age, sex, age × sex,
age2, and age2 × sex as covariates. Error bars represent 95% confidence intervals. Significant regions are highlighted in orange.
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project to posterior parietal, temporal and occipital cor-
tices, and include many major association fibers (including
the UNC) where altered microstructure may be related to
clinical phenomenology38,39. Our findings are consistent
with a range of work indicating altered connectivity outside
the fronto-striatal circuit in OCD. For example, results of a
multimodal structural imaging study suggested that
patients with OCD show significant alterations of the
interrelated gray and WM networks over occipital and
parietal cortices, frontal interhemispheric connections, and
cerebellum40. Also, decreased functional connectivity in the
occipital cortex, temporal cortex, and cerebellum has been
shown in OCD41. Finally, there is evidence in OCD of
associations between structural and functional alterations
in a complex network including, beyond orbitofrontal and
cingulate areas, temporal and occipital cortices42.
We only partially replicate previous large meta-analytic
findings demonstrating the validity of both the classic fronto-
striatal model of the disorder3 and the more recent multiple
brain system approach11,43. The present findings are based
on the TBSS technique, which by reducing WM tracts into a
skeleton, confines statistical testing to a selective group of
voxels through a constrained local search for maximal FA.
Such an algorithm may therefore produce more consistent
results, but also more conservative ones, thus explaining the
lack of case/control group differences in more anterior WM
structures found in previous meta-analysis where whole-
brain WM volumetric and FA studies were combined3.
Notably, in our study WM microstructural alterations
in OCD were associated with age at scanning. Specifically,
WM alterations were observed in the adult cohort only,
and were associated with longer illness duration. These
findings, which were unrelated to OCD symptom severity,
complement previous evidence of differences between
adult and pediatric OCD patients in brain morphologi-
cal3,10,44 and clinical45 correlates.
There is evidence that the human brain’s protracted
myelination46,47 underpins myelin vulnerability along a
Fig. 2 Association between FA reduction (in OCD adult patients) in the sagittal stratum and illness duration (green dots), age of onset (blue
dots) and percentage of medicated patients across the 11 ENIGMA-OCD sites. Sphere magnitude indicates sample size.
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continuum from early to late stages of development and
disease48. Thus, it has been suggested that pediatric OCD
could be a neurodevelopmental disorder with potentially
differing patterns of myelination occurring throughout life49.
Indeed, evidence in healthy subjects indicates that the psy-
chiatric trait of compulsivity is linked to reduced myelin
growth that emerges only during adolescence (being present
only to a minor extent in childhood) as a result of aberrant
developmental processes23. Alternatively, pediatric OCD
might be a developmentally moderated expression of etiologic
processes that are shared with the adult clinical phenotype.
A number of limitations of the data analyzed here deserve
emphasis. First, although TBSS is a widely used method for
voxel-based analysis of WM, addressing issues associated
with smoothing and misalignment in DTI group analysis37,
the technique has some limitations. Indeed, by reducing
WM tracts into a skeleton, delineating the center of the
tracts and projecting onto it only the highest FA value along
the projection, some information might be lost50, and
potential artifacts, resulting from misregistration, might be
produced51. Nevertheless, several test–retest and reliability
analyses were conducted by the ENIGMA-DTI working
group to ensure reproducibility of measures and effects
using this TBSS approach52. Future investigations combin-
ing various imaging modalities in the same meta-analysis
and both pre-analyzed and raw data53 will potentially offer
insights that are not apparent from the TBSS approach.
Moreover, a word of caution is needed regarding the
interpretation of the neurobiological basis of DTI measures
since although FA reflects the myelination, orientational
Table 4 FA meta-analysis metrics for the pediatric sample.
Effect size and 95% confidence interval Heterogeneity
ROI Cohen’s d S.E. Lower limit Upper limit z value p value q value p value I squared
ACR 0.035 0.111 −0.183 0.254 0.318 0.751 4.154 0.762 0.000
ALIC 0.103 0.145 −0.180 0.386 0.711 0.477 11.207 0.130 37.538
AverageFA 0.077 0.111 −0.142 0.295 0.687 0.492 5.421 0.609 0.000
BCC 0.011 0.138 −0.260 0.282 0.079 0.937 10.316 0.171 32.143
CC −0.013 0.117 −0.242 0.217 −0.108 0.914 7.596 0.370 7.844
CGC 0.111 0.112 −0.107 0.330 0.997 0.319 6.212 0.515 0.000
CGH −0.017 0.143 −0.296 0.263 −0.116 0.908 10.928 0.142 35.946
CR 0.022 0.111 −0.196 0.240 0.197 0.844 5.042 0.655 0.000
CST −0.110 0.153 −0.409 0.189 −0.723 0.469 12.410 0.088 43.593
EC −0.025 0.111 −0.244 0.193 −0.226 0.821 5.000 0.660 0.000
FX −0.119 0.111 −0.337 0.099 −1.072 0.284 1.237 0.990 0.000
FXST −0.095 0.134 −0.357 0.168 −0.707 0.480 9.725 0.205 28.020
GCC −0.018 0.111 −0.236 0.201 −0.158 0.875 4.635 0.704 0.000
IC 0.013 0.111 −0.205 0.231 0.116 0.907 3.551 0.830 0.000
IFO −0.025 0.111 −0.243 0.193 −0.228 0.819 2.937 0.891 0.000
PCR 0.078 0.116 −0.149 0.305 0.676 0.499 7.443 0.384 5.958
PLIC 0.026 0.111 −0.192 0.244 0.237 0.813 2.079 0.955 0.000
PTR −0.004 0.201 −0.398 0.390 −0.022 0.982 21.204 0.003 66.987
RLIC −0.067 0.111 −0.285 0.151 −0.602 0.547 5.021 0.657 0.000
SCC −0.036 0.112 −0.255 0.183 −0.321 0.748 6.867 0.443 0.000
SCR −0.040 0.111 −0.258 0.178 −0.357 0.721 4.165 0.761 0.000
SFO 0.100 0.155 −0.203 0.404 0.649 0.516 12.757 0.078 45.127
SLF −0.089 0.116 −0.317 0.139 −0.763 0.446 7.519 0.377 6.904
SS 0.006 0.146 −0.280 0.292 0.041 0.967 11.433 0.121 38.775
UNC 0.053 0.119 −0.181 0.286 0.441 0.659 7.840 0.347 10.711
Cohen’s d values, their s.e., lower and upper limits, p values and I2 (heterogeneity) values after meta-analysis for differences between OCD patients and healthy controls.
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coherence, and microtubular axonal structure of fibers,
other in vivo markers not explored in the present study have
been shown to be a more direct reflection of myelination
status54,55. Another potential limitation of the present study
may lie in the differences in clinical characteristics between
the studied patients, particularly in the average age of onset
(which ranged from 4 to 49). Since the latter is often cal-
culated retrospectively, a reliable and unanimous method for
establishing this important effect moderator is warranted.
Also, we were not able to calculate specific dosages of dif-
ferent medication types and analyze medication effects in
terms of drug dosages or total time of treatment and, as
such, potential detrimental/normalizing effects of different
medications could not be tested. Furthermore, while dis-
order severity was assessed cross-sectionally at the time of
the scan, WM integrity reflects a process that occurred
longitudinally over time and this could explain the absence
of disorder severity effects. Lastly, it is worth mentioning
that while the adult cohort analysis had sufficient power to
detect the observed effect size, as the sample size was ade-
quate to detect microstructural differences as small as d=
0.15, the null result in the pediatric cohort may be a con-
sequence of the relatively small sample size since the power
for potentially detecting even very small differences was low
(0.32). Nevertheless, this is the largest pediatric dataset
investigated in a DTI study of OCD.
In summary, our results clearly indicate a key role in
adult OCD for microstructural alterations in projection
and association fibers to posterior brain regions. Our
meta-regression results related to duration suggest that
microstructural alterations may persist during the course
of the illness, although longitudinal data are needed to
confirm such trajectories. Future studies to investigate the
co-occurrence of abnormal WM microstructure, GM
volume and metabolic differences in OCD may shed light
on the interactions and trajectories of structural and
functional alterations in this condition. In particular,
longitudinal designs, and collecting information from
patients at their illness onset, combined with multimodal
MRI approaches, such as volumetric, DTI, fMRI, and
MRS will help provide an understanding of the timing and
course of brain changes in OCD, and provide greater
insight into the mechanisms involved in various stages of
OCD, including the long-term effects of medication.
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